Stock Price
1,173.28
Daily Change
26.38 2.30%
Monthly
6.46%
Yearly
51.11%
Q3 Forecast
1,154.35

EPS Reference Time Actual Consensus Previous
2026-10-29 FY2026Q3 AM 9.46 7.02
2026-08-05 FY2026Q2 AM 8.82 6.31
2026-04-30 FY2026Q1 AM 8.55 7.25 3.34
2026-02-04 FY2025Q4 AM 7.54 7.16 5.32
2025-10-30 FY2025Q3 AM 7.02 6.36 1.18



Peers Price Chg Day Year Date
AbbVie 256.13 2.75 1.09% 36.89% Jul/21
Abbott 99.71 -1.95 -1.92% -20.70% Jul/21
ALKERMES 52.07 -0.65 -1.23% 78.20% Jul/20
Amgen 362.45 -1.72 -0.47% 18.57% Jul/21
AstraZeneca 12,492.00 112.00 0.90% 20.67% Jul/21
Baxter International 22.15 0.08 0.36% -19.48% Jul/21
Biogen 202.74 2.79 1.40% 58.58% Jul/21
Bristol-Myers Squibb 60.88 0.72 1.20% 26.78% Jul/21
Coherus Biosciences 1.44 0.02 1.06% 55.59% Jul/21
Gilead Sciences 130.25 -2.96 -2.22% 18.23% Jul/21

Indexes Price Day Year Date
US500 7502 65.92 0.89% 17.98% Jul/22

Eli Lilly traded at $1,173.28 this Tuesday July 21st, increasing $26.38 or 2.30 percent since the previous trading session. Looking back, over the last four weeks, Eli Lilly gained 6.46 percent. Over the last 12 months, its price rose by 51.11 percent. Looking ahead, we forecast Eli Lilly to be priced at 1,154.35 by the end of this quarter and at 1,083.14 in one year, according to Trading Economics global macro models projections and analysts expectations.

Eli Lilly and Company is a drug manufacturing company. The Company discover, develop, manufacture, and market products in a human pharmaceutical product segment. The Company’s products include Diabetes and other endocrinology products, including Baqsimi, Basaglar, Forteo, Humalog, Humatrope, Humulin, Jardiance, Trajenta and Trulicity. Its Immunology products include Olumiant and Taltz. Its Neuroscience products include Cymbalta, Emgality, Reyvow, Strattera and Zyprexa. Its Oncology products include Alimta, Cyramza, Erbitux and Verzenio. Other product includes Cialis, for the tratment of erectile dysfunction and benign prostatic hyperplasia. The Company manufacture and distribute its products through facilities in the United States, Puerto Rico, and 8 other countries. Its products are sold in approximately 120 countries.



News Stream
Eli Lilly Stock Price Hits 11-week High
Eli Lilly shares increased to 1026.00 USD, the highest since March 2026. Over the past 4 weeks, Eli Lilly gained 11.01%, and in the last 12 months, it increased 36.71%.
2026-05-20
Eli Lilly Stock Price Hits 4-week High
Eli Lilly shares increased to 967.48 USD, the highest since April 2026. Over the past 4 weeks, Eli Lilly gained 4.47%, and in the last 12 months, it increased 21%.
2026-05-01
Eli Lilly Stock Price Hits 4-week Low
Eli Lilly shares decreased to 880.93 USD, the lowest since March 2026. Over the past 4 weeks, Eli Lilly lost 2.38%, and in the last 12 months, it increased 2.53%.
2026-04-24